文献速递脑血管病外科神经重症

蛛网膜下腔出血后迟发性脑缺血的强化治疗:两种中心驱动策略的倾向匹配比较

Intensive therapies of delayed cerebral ischemia after subarachnoid hemorrhage: a propensity-matched comparison of different center-driven strategies.
PubMed 文献 · Acta Neurochir (Wien) · 2021-07-24

该研究比较了两个北欧中心对动脉瘤性蛛网膜下腔出血后迟发性脑缺血(DCI)的两种强化治疗策略:介入中心以血管痉挛血管成形术(远端经皮球囊血管成形术联合静脉米力农)作为一线治疗,非介入中心仅用诱导高血压。

要点

  • 两种中心驱动策略对DCI的强化治疗疗效无显著差异。
  • 介入中心38%患者接受血管痉挛血管成形术,中位时间为出血后8天。
  • 结果提示此类强化治疗在日常实践中需进一步优化和验证。

核心结论

  • 两种中心驱动策略对DCI的强化治疗可能无获益或获益极小。

主要发现

  • 介入中心38%患者行血管痉挛血管成形术,中位时间为出血后8天(Q1=6.5;Q3=10)。
  • 影像学DCI发生率介入中心9% vs. 非介入中心14%(P=0.11)。
  • 1个月死亡率介入中心8% vs. 非介入中心9%(P=0.4)。
  • 6个月良好预后(mRS≤2)介入中心74% vs. 非介入中心72%(P=0.4)。
  • 上述比较在倾向评分匹配前后均无显著差异。

临床怎么用

  • 对于aSAH后DCI,血管痉挛血管成形术联合静脉米力农作为一线策略与仅诱导高血压相比未显示显著优势。
  • 在日常实践中使用此类强化治疗前应进一步优化和验证。

局限性

  • 研究可能存在把握度不足或未知混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intensive therapies of delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH) have still controversial and unproven benefit. We aimed to compare the overall efficacy of two different center-driven strategies for the treatment of DCI respectively with and without vasospasm angioplasty. METHODS: Two hundred consecutive patients with aSAH were enrolled in each of two northern European centers. In an interventional center, vasospasm angioplasty was indicated as first line rather than rescue treatment of DCI using distal percutaneous balloon angioplasty technique combined with intravenous milrinone. In non-interventional center, induced hypertension was the only intensive therapy of DCI. Radiological DCI (new cerebral infarcts not visible on immediate post-treatment imaging), death at 1 month, and favorable outcome at 6 months (modified Rankin scale score ≤ 2) were retrospectively analyzed by independent observers and compared between two centers before and after propensity score (PS) matching for baseline characteristics. RESULTS: Baseline characteristics only differed between centers for age and rate of smokers and patients with chronic high blood pressure. In the interventional center, vasospasm angioplasty was performed in 38% of patients with median time from bleeding of 8 days (Q1 = 6.5;Q3 = 10). There was no significant difference of incidence of radiological DCI (9% vs.14%, P = 0.11), death (8% vs. 9%, P = 0.4), and favorable outcome 74% vs. 72% (P = 0.4) between interventional and non-interventional centers before and after PS matching. CONCLUSIONS: Our results suggest either that there is no benefit, or might be minimal, of one between two different center-driven strategies for intensive treatment of DCI. Despite potential lack of power or unknown confounders in our study, these results question the use of such intensive therapies in daily practice without further optimization and validation.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Labeyrie MA, Simonato D, Gargalas S, et al. Intensive therapies of delayed cerebral ischemia after subarachnoid hemorrhage: a propensity-matched comparison of different center-driven strategies. Acta Neurochir (Wien). 2021. PMID: 34302553. doi:10.1007/s00701-021-04935-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。